Search

everythinglearnresearchcommunity

for

Search:↓

The document concluded that FDA-approved treatments like minoxidil and finasteride are effective for hair loss, while the effectiveness of natural remedies and other non-approved treatments is not well-supported by evidence.

The document discussed hair loss causes and treatments but didn't give a final summary.

The document concludes that early diagnosis and treatment of PCOS in teenagers is important for managing symptoms and preventing long-term health problems.

The document concludes that accurate diagnosis and treatment are crucial in dermatology, and it presents various findings on skin conditions and treatments.

The document concludes that antiandrogenic drugs like cyproterone acetate and spironolactone are effective but not permanent treatments for skin-related androgenization in women.

The document highlights recent findings and treatments in urology, including prostate cancer diagnostics, urinary incontinence, and new therapies.

The document concludes that managing hirsutism in PCOS involves long-term treatment guided by severity, using oral contraceptives and possibly antiandrogens, with attention to individual patient needs.

The review suggests thorough evaluation and genetic testing for proper diagnosis and treatment of Chrousos syndrome.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

Chaga mushrooms contain compounds that may promote hair growth better than common treatments.

Hair loss in women can be slowed with treatment, but more research needed for better solutions.

The mouse model could be useful for baldness research and testing treatments like testosterone, cyproterone acetate, and minoxidil.

Don't combine abiraterone and spironolactone for prostate cancer treatment as it may worsen the disease.

Analog 23 is a promising compound for prostate cancer treatment.

Ethinylestradiol/chlormadinone acetate may be an effective and well-tolerated treatment for skin conditions caused by excess androgens.

Atypical male hair loss may not respond to usual treatments.

Gender-affirming hormone therapy affects metabolism differently based on treatment type.

Topical finasteride might be a good alternative for hair loss treatment with fewer side effects, but more research is needed.

Effective management of hyperandrogenism in young women requires accurate diagnosis and tailored treatment.

Blood tests for tumor cells could improve prostate cancer diagnosis and treatment; hair loss severity linked to a gene affecting prostate conditions.

Topical minoxidil is the primary treatment for female pattern hair loss in India.

Genetic differences in hair loss can help improve diagnosis and treatment.

Insulin-lowering medications show promise for PCOS symptoms but can't be the main treatment yet due to limited long-term research.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

Most hirsutism cases are due to PCOS, and treatment focuses on lowering testosterone and blocking its effects.

The document concludes that understanding dermal papilla cells is key to improving hair regeneration treatments.

Isotretinoin improves severe acne without changing androgen or insulin levels but may increase body weight and triglycerides.

Topical antiandrogens might treat skin issues like hair growth, balding, and acne, but finding effective treatments without side effects is challenging.

Untreated congenital adrenal hyperplasia can lead to complications like stroke and needs glucocorticoid treatment.